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Summary
Background The increasing incidence of actinic keratosis (AK) is causing a large bur-
den on healthcare systems. The current management of patients with AK seems to
vary within and between primary and secondary care; however, an in-depth
understanding of healthcare providers’ management of AK is currently lacking.
Objectives To gain insight into the management of AK by exploring the underlying
motives of current practices among general practitioners (GPs) and dermatolo-
gists in the Netherlands.
Methods A qualitative study was conducted consisting of semistructured individual
interviews with 22 GPs and 18 dermatologists focusing on the underlying
motives regarding AK management. A predefined topic list was used. All inter-
views were audiotaped, transcribed verbatim and inductively analysed by two
researchers drawing on elements of grounded theory.
Results GPs reported conducting limited proactive clinical assessments of cuta-
neous photodamage due to a perceived lack of value, varying in their method
of diagnosing AK. They mainly applied cryotherapy or referred to secondary
care due to lack of experience, varying in their applications and providing
mostly patient-driven follow-up care. They also reported a great need for
guidelines due to a lack of knowledge of AK management. Dermatologists indi-
cated pursuing proactive clinical assessments of cutaneous photodamage and the
goal of providing guideline-driven AK care. However, patient preferences still
largely influence both treatment choices and follow-up regimens. Furthermore,
dermatologists reported the need to improve AK and skin cancer management
in primary care.
Conclusions For AK care to become more standardized and uniform in Dutch pri-
mary care, the implementation of guidelines and (continuing) education are
needed to address the commonly reported barriers of lack of value, experience
and knowledge among GPs. For efficient use of care among dermatologists,
shared decision-making tools along with adequate (framing of) patient informa-
tion may be useful.
What’s already known about this topic?
• Actinic keratosis (AK) is a high-volume condition with a significant healthcare
impact.
• The current management of patients with AK seems to vary within and between
primary and secondary care; however, an in-depth understanding of AK manage-
ment by healthcare providers is currently lacking.
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What does this study add?
• This qualitative study provides insight into the underlying motives of current AK
management.
• General practitioners (GPs) reported varying in diagnosing AK and in determining
treatment and follow-up schedules. Commonly reported motives were a lack of
knowledge and experience and low perceived value of AK care.
• Dermatologists indicated that they strived to provide guideline-driven AK care.
However, patient preferences and other patient-related factors influence treatment
choices and often lead to extensive follow-up regimens.
What are the clinical implications of this work?
• For GPs to provide more standardized and uniform AK care, it seems useful to
invest in improving GPs’ knowledge of AK through continuing education and ade-
quate implementation of the primary care guideline among GPs.
• Shared decision-making tools along with adequate (framing of) patient information
may be useful to facilitate dermatologists’ management of patient preferences,
thereby preventing extensive follow-up.
Actinic keratosis (AK) is a chronic skin condition caused by
long-term sun exposure. AK is the most common premalig-
nant skin condition, and its incidence is steadily increasing.1–3
Prevalence rates vary among the different countries and popu-
lations under review;4–8 estimates from population-based data
show that 24% (Netherlands) to 60% (Australia) of people
above the age of 50 years have at least one AK. The large and
increasing number of patients with AK presents a challenge
for healthcare systems.
In the Netherlands, as in many other European countries,
both general practitioners (GPs) and dermatologists are involved
in medical care of patients with AK. Dutch GPs are the gatekeep-
ers to specialist care and can decide either to treat the patient
themselves or to refer the patient to a medical specialist.9 The
recently published primary care guideline on ‘suspicious cuta-
neous lesions’ from the Dutch College of General practitioners
(in Dutch: Nederlands Huisartsen Genootschap) provides rec-
ommendations on the management of AK by GPs.10,11 Although
AK is considered to require low-risk care that can be provided
by the GP, a rather substantial proportion of patients are referred
to secondary care, resulting in 40 000 new dermatology consul-
tations annually.12 Dermatologists, who have been equipped
with national AK guidelines since 2010, still have a prominent
role in the diagnosis and treatment of AK.1,3,10
As AK is a high-volume condition, it requires an optimal
use of resources. A previous study showed that AK manage-
ment varies within and between primary and secondary
care.12 However, an in-depth understanding of healthcare pro-
viders’ management of AK is currently lacking. The aim of this
qualitative study was therefore to gain insight into the man-
agement of AK by exploring the underlying motives of current
practices regarding the diagnosis, treatment and follow-up of
AK among GPs and dermatologists.
Patients and methods
Study design
A qualitative study was conducted consisting of 22 one-on-one
semistructured interviews with GPs and 18 one-on-one
semistructured interviews with dermatologists. Individual inter-
views were considered the most appropriate method to explore
current practices and underlying motives, as they encourage
participants to propagate their views and opinions freely.13–17
Selection of participants
Purposive sampling was used in the identification and selec-
tion of information-rich participants for the subject of inter-
est.18 Potential participants were selected through the authors’
personal networks. To create a sample with maximum varia-
tion, we took age, sex, setting and years of professional expe-
rience of GPs and dermatologists into account. Initially, five
GPs and five dermatologists were invited to participate in a
pilot study. This invitation was extended to 22 GPs and 18
dermatologists in total. Potential participants received an invi-
tation by e-mail containing an information leaflet about the
study. Physicians could register for participation by contacting
one of the researchers.
Data collection
The interviews were conducted immediately prior to the issu-
ing of the primary care guideline (June 2017). All interviews
were conducted by an experienced independent qualitative
researcher (M.L.) either in a face-to-face setting (n = 28) or
by telephone (n = 12). A predefined topic guide based on
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prior experiences of the authors12,19,20 was used for the inter-
views and included the following main themes: AK care in
general, diagnosis of AK, treatment of AK and follow-up care
of AK (Appendix S1; see Supporting Information). Participants
were asked to complete a short questionnaire to provide
demographic information. In addition to AK, physicians were
also asked about management concerning basal and squamous
cell carcinomas; this information falls outside the scope of this
paper. After the pilot, only minor changes were made to the
topic guide. All interviews were audiotaped with the consent
of the participants and were subsequently transcribed verbatim
anonymously.
Data processing and analysis
Transcripts were imported to ATLAS.ti 8.0 for analysis
(ATLAS.ti, Berlin, Germany). An inductive approach to data
analysis was applied drawing on elements of grounded theory
(e.g. open coding, constant comparison).17 Two researchers
(E.C.N., S.vE.) independently openly coded the first four tran-
scripts.17 The obtained codes were discussed by the research
team (E.C.N., S.vE., M.L.) and adjusted when needed. This
resulted in a preliminary thematic coding scheme. This frame
was applied to all transcripts, which were coded by one
researcher (E.C.N. or S.vE.) and subsequently checked by a sec-
ond researcher (E.C.N. or S.vE.). New codes were created until
needed. Differences in (new) codes were discussed and refined
until agreement between the researchers was reached. After 18
interviews with dermatologists and 22 interviews with GPs, the-
matic saturation, which was defined as little or no changes made
to the codes, was reached in all research areas.21
Iterative and interpretive constant comparison followed the
initial coding phase.17 Different codes were compared, and
the relationship between codes was explored to detect emerg-
ing themes. This process was performed separately and inde-
pendently for codes of GPs and dermatologists; for
comparable themes, the same terms were used.
Ethical considerations
Ethical approval for this study was granted by the medical
ethics committee of the Erasmus University Medical Center in
Rotterdam (MEC-2016-204). All participants provided written
informed consent. This qualitative study was designed and
reported in accordance with the recommendations of SRQR
(Standards for Reporting Qualitative Research), which aims to
improve the transparency of qualitative research by providing
reporting standards.22
Results
Description of participants
Of the 22 participating GPs, 68% were male and the median
age was 41 years (Table 1). Two physicians in the GP group
were residents. Of the 18 participating dermatologists, 56%
were male and the median age was 45 years. One-half worked
in a peripheral hospital (n = 9).
Management of actinic keratosis
Five main themes emerged from the data for GPs and four
main themes for dermatologists. These themes are described
in detail below. Additional illustrative quotations for each
theme are presented in Appendix S2 (see Supporting Informa-
tion).
General practitioners
Limited proactive clinical assessment of cutaneous
photodamage due to perceived lack of value
Most GPs reported never proactively assessing cutaneous pho-
todamage, and others reported only assessing photodamage
when it is highly noticeable in patients or when it concerns
high-risk patients. Reported reasons for these limited proac-
tive cutaneous photodamage assessments were mainly a per-
ceived lack of value and need due to the low risk of AKs, as
well as a lack of time to perform an additional evaluation. In
addition, they stated that it is not part of their routine or
system, and they questioned whether this should be a task
for GPs, as they are trained only to respond to the requests
of patients.
However, some GPs are more actively involved in proactive
cutaneous photodamage assessments and indicated either
always discussing cutaneous photodamage with patients or
conducting assessments when they believe they are necessary.
In contrast to other GPs, they consider this practice to be of
great importance.
Table 1 Characteristics of participants
Characteristic GPs Dermatologists
Total 22 18
Male, n (%) 15 (68) 10 (56)
Age (years), median (IQR) 41 (38–53) 45 (38–54)
Years of professional experience,
median (IQR)
8 (6–23) 12 (6–20)
Dermatologists
Academic hospital N/A 2 (11)
Peripheral hospital N/A 9 (50)
ISTC N/A 3 (17)
Combination of the above N/A 4 (22)
GPs
Individual practice 6 (27) N/A
Group practice 15 (68) N/A
Medical centre 1 (5) N/A
IQR, interquartile range; ISTC, independent-sector treatment centre;
GP, general practitioner; N/A, not applicable.
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‘No, or it has to be something melanoma-like, but if it
is just actinic, no, that is not part of my routine. (. . .)
The risk is also very low, only a few per cent.’ (GP
interview 7)
‘In specialist training GPs are trained to do anamnesis
to identify the request and if you then discuss some-
thing different with the patient, well, that is then of
course the opposite of what you are taught. The patient
is not coming for the keratosis, but of course you can
say ‘I see you are a sun lover, I think it is wise to have
your skin check sometime’. But that is not in our stan-
dard for now, no I don’t think GPs do this.’ (GP inter-
view 18)
Varying but mostly clinical diagnosis of actinic keratosis
GPs seem to vary in their method of diagnosing AK. Most GPs
reported AK to be a clinical diagnosis and to start treatment
pragmatically. Ineffective treatment may subsequently be a
reason to perform a biopsy or to refer to a dermatologist.
Some GPs mentioned never using biopsies and always refer-
ring patients to a dermatologist as they do not treat patients
with AK themselves. Reported motives for not performing a
biopsy were the perceived lack of added clinical value, the
lack of experience with performing biopsies, unnecessary
additional costs, the need to treat a patient twice (i.e. biopsy
and subsequent excision in case of malignancy), the feeling of
‘messing around’ with a malignant tumour, and not wanting
to treat it anyway.
However, other GPs stated using a biopsy as a diagnostic
tool for confirming AK on a more regular basis and even pro-
moting the use of biopsies among colleagues. Low costs and
receiving a definitive diagnosis on short notice were also men-
tioned as reasons to perform a biopsy. Other motivations were
the direct learning effect of a biopsy and that it may increase
the patient’s motivation regarding treatment. Other diagnostic
tools reported by GPs used in the diagnosis of AK were (tele)-
dermatoscopy and teledermatology.
‘I depend on my safe–unsafe feeling, that’s how it
works. And eh, does it need to be removed or not, and
that differentiation seems to work better most of the
times than to have a very specific diagnosis.’ (GP inter-
view 2)
‘When in doubt, to be sure. It is of course low cost and then
you know what it is. I wouldn’t dare to just use cryotherapy
and say oh it will be all right.’ (GP interview 1)
Use of cryotherapy as the main therapy due to a lack of
experience with alternatives
GPs seem to vary in their treatment of AKs. While some GPs
stated that they treat most patients themselves and only refer
certain cases, others reported that they instantly refer all
patients with AK to a dermatologist. Motives to refer patients
are the lack of a primary care guideline (and therefore a lack
of knowledge and confidence to treat AKs), believing that
GPs should not be administering cryotherapy or topical treat-
ments, and the need for a dermatologist to propose the indi-
cation for treatment. Other factors that were reported to
influence referral included treatment failure, uncertainty
about the diagnosis, extensive or progressive AK, AK located
on the face, patients with a history of skin cancer and patient
preferences.
GPs treating patients with AK reported cryotherapy as the
main treatment modality. Some GPs reported cryotherapy to
be the only treatment modality used regardless of AK exten-
siveness because they lack knowledge, experience and/or
competence regarding other therapies. However, some GPs
stated a willingness to add topical field treatment to their ther-
apeutic arsenal if they received clear instructions such as
guidelines for use.
A smaller group of GPs reported using various treatment
strategies, including topical drugs. They mentioned using
cryotherapy when AK is less extensive or due to reservations
regarding therapy compliance. When AK is extensive or after
cryotherapy is ineffective, these GPs reported preferring topical
treatment. When choosing between different treatment modal-
ities, some GPs reported taking into account associated costs
and patients’ age and preferences. Furthermore, it was men-
tioned that AKs might be excised if this is requested by the
patient.
‘Those AKs, with that cream I think we are not allowed
to prescribe that, right, that Aldara. That’s what I
thought. (. . .) I also think we are not supposed to apply
nitrogen.’ (GP interview 21)
‘Sometimes the AK is so extensive, then I need to dip
his whole head in nitrogen. Eh, yes or treat it with
topicals, such like Aldara, but I don’t feel competent to
treat such large areas, so those patients I tend to refer
to a dermatologist.’ (GP interview 9)
‘In principle I do the treatment myself, and when
despite that it’s coming back or is very persistent, I
refer to a dermatologist for example for Efudix treat-
ment. And I don’t do that myself because I do not have
any experience with that. I know that it often gives
blisters and that kind of things, and that’s why I don’t
do it, but maybe if I could get training for that that I
might be able to do it.’ (GP interview 19)
‘We [in our GP practice] always treat AK ourselves,
only when it is an extreme large area such its total
head, or three-quarters of the thoracic region what we
last saw, then we don’t do it. But the average patient
with smaller areas, mostly on the head, we do the
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treatment ourselves. And depending on the shape, size
and sharpness of the edges we sometimes use cryother-
apy, and often Efudix or Picato.’ (GP interview 3)
Variable and mainly patient-driven follow-up care
GPs seem to vary in their follow-up schedules for patients
with AK in terms of both frequency and content of follow-up.
Some GPs stated opting for a clear follow-up schedule
(although with varying frequency) because AK is a chronic
skin condition, which they believe requires monitoring, and
given the risk of AK progressing into squamous cell carci-
noma. Other GPs place the responsibility in the hands of the
patient and do not schedule regular follow-up visits, due to
the perceived lack of value of follow-up care given the low
risk of AK and its time-consuming nature or because they
believe it will result in overdiagnosis. Additionally, GPs stated
a lack of knowledge on what is needed for AK follow-up care.
Regarding the content of follow-up visits, some GPs
reported conducting full-body skin examinations (FBSEs),
while others reported not performing them due to a perceived
lack of value or because it is too time-consuming within their
already restricted consultation time. Furthermore, some GPs
mentioned that they do not feel competent to perform an
FBSE, and it would offer false security to the patient as the
GPs question the quality of the FBSE. However, GPs perform-
ing FBSEs advocate the notion that skin cancer does not only
occur on sun-exposed areas; therefore, there is a need to
check all of the skin.
‘It is the question whether it [FBSE] is necessary. The
patients also come to you the first time, so they have
found it themselves. And eh, so to check everyone,
well, I think that that would be just overdiagnosing. I
think that would be way too time-consuming.’ (GP
interview 5)
‘Yes, I do follow up on it. And I also explain prevention,
like wearing hats, use SPF. But I mean, I order them back
often. (. . .) Actually more from moment to moment. It is
not that I have a clear schedule, but when I think it is
becoming less, then I say like ‘you know, see how it goes
and if it comes up again then you can come back’. I don’t
have a special guideline for this.’ (GP interview 22)
‘No, well yes, maybe it [not performing a FBSE] has to
do with the hesitation and the idea of then I might
miss things, kind of false security.’ (GP interview 4)
‘It is not always the case that they [cutaneous (pre)ma-
lignancies] are on sun-exposed areas. Because it is still
the question if it is related to UV exposure, we don’t
know this for sure yet, we think it is but it is still ques-
tioned. It is often located on places the sun doesn’t
reach.’ (GP interview 1)
Need for a primary care skin cancer guideline in actinic
keratosis management
GPs expressed a high need for guidelines in AK (and skin can-
cer) management in primary care due to a perceived lack of
knowledge on AK management. The GPs mentioned that
guidelines would influence their management of AKs, reduce
unnecessary referrals and increase the proportion of patients
treated in primary care. However, they also stated that imple-
mentation depends on the type and interest of the GP and that
a guideline on its own would not be sufficient to make a dif-
ference. Therefore, GPs commented that the issuing of the
guideline must be accompanied by education.
‘Now you have to depend on if it is your own hobby
how far you go with it. And now there are clear guide-
lines what you could do and maybe can take you a step
further that you do now, such as with Efudix cream for
instance what you can do with that. GPs are hesitative
with that.’ (GP interview 6)
‘It is a good case there is a guideline for primary care
coming. (. . .) It is important business, and eh derma-
tology, I think that for many GPs it keeps being tough,
ehm look, we see the whole iceberg. And the dermatol-
ogist only sees the tip of the iceberg. We need to sepa-
rate the chaff from the wheat, and that makes it hard.’
(GP interview 16)
‘Primary care has a very broad spectrum, and there are
many guidelines. What we have seen in the past 20
years is that with every issuing of a new guideline, pri-
mary care has shaped itself around that guideline. And
ehm, I expect that this suspicious lesions guideline will
give some direction to what GPs will offer in general,
but there will always be GPs who don’t like it, and that
will stay the same. Also if the guideline will say they
can do it, I don’t think they will naturally. So it
depends on what type of GP you are, do you like it,
can you do it. Well, everybody has their own
specialty.’ (GP interview 3)
Dermatologists
Proactive clinical assessment of cutaneous photodamage
is generally pursued
Whereas some dermatologists reported never failing to con-
duct a clinical assessment of cutaneous photodamage proac-
tively, others restrict this to high-risk patients or to patients
with obviously photodamaged skin. In general, dermatologists
reported pursuing proactive photodamage assessment in every
patient. However, whether to conduct an assessment consti-
tutes an internal struggle. On one hand, they stated experienc-
ing barriers in terms of time restrictions and increasing
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waiting lists. On the other hand, they do not want to make
mistakes and want to provide the best possible care.
‘You always look at it, but it is not like. . .there is too
little time to fully undress everyone, and do an FBSE.’
(Dermatologist interview 9)
‘Yes look, if someone consults me for varicose veins and I
look at those legs and a half year later that person appears
to have metastasized melanoma on the leg, then I think
that I have dropped a few stitches. And that is not going to
happen to me of course.’ (Dermatologist interview 7)
Guideline-driven choice of treatment and taking into
account patient preferences
Dermatologists generally reported treating AKs using a wide
range of treatment modalities, but some stated that they do
not treat all AKs (or patients) due to the low risk of AK pro-
gression.
Regarding the underlying motives concerning treatment
choices, dermatologists generally indicated that treatment is
guideline driven, taking into account factors such as AK exten-
siveness, location, costs, season, prior effects and side-effects.
In addition, patient factors and, in particular, patient prefer-
ences were stated to play an important role. Patient factors
that were said to influence the choice of treatment were age,
sex, cosmetics, burden for the patient and patient motivation.
With respect to patient preferences, dermatologists reported
often applying shared decision making when choosing a speci-
fic treatment. Dermatologists mentioned that patients with AK
increasingly comprise a younger group who in general want
to be (more) involved in decision making. According to some
dermatologists, shared decision making also improves patients’
compliance to therapy and keeps patients satisfied.
Dermatologist ‘I also do nothing often, so then I
think, yes.’
Interviewer ‘What is the reason for that?’
Dermatologist ‘You can also just keep an eye on it,
and not treat it. Basically it is not an
early stage, more a precursor, so it not
necessarily becomes skin cancer.’
(Dermatologist interview 9)
‘It is customized. It depends on the patient, the lesion,
if it is solitaire or multiple, the localization.’ (Dermatol-
ogist interview 15)
‘There are also guys that don’t want to use topical
creams because it hinders them, they are just not that
into creams. They just say, I’m not interested, just do
30 times cryotherapy and I’ll come back more often.
(. . .) If you want patients to come back, you need to
take their preferences into account. Of course within
limits.’ (Dermatologist interview 7)
Patient-driven extensive follow-up regimens
Dermatologists mentioned risk differentiation (in relation to the
extensiveness of AK) to determine follow-up schedules,
although follow-up is often extensive and, in some cases, life-
long. Aside from risk differentiation, dermatologists indicated
follow-up regimens to be largely patient driven (e.g. patient
preferences, patients being used to follow-up consultations,
patients who are less capable of checking themselves), often
resulting in extensive follow-up schedules. In addition, they
mentioned checking younger patients more extensively than
older patients. Extensive photodamage is also reported to be a
factor in opting for more extensive follow-up schedules. How-
ever, some dermatologists attribute the responsibility exclu-
sively to the patient or GP. They argued that it is unnecessary to
perform follow-up checks for these patients and believe it is not
manageable to keep all patients with AK in secondary care.
Other factors influencing follow-up regimens according to
dermatologists are doubt about the presence of squamous cell
carcinoma and having prescribed topical treatments. Furthermore,
dermatologists reported that financial incentives might contribute
to more extensive follow-up; however, they noted this to be the
case only for their colleagues and not for themselves.
Interviewer ‘How often do you see patients for
follow-up?’
Dermatologist ‘Often those patients come back once a
year. (. . .) They are kind of used to it, I
try to discharge part of them, because part
of them can easily go to the GP, but well,
I have a lot of people who come to the
dermatologist on a yearly basis at their
own request.’ (Dermatologist interview 9)
Interviewer ‘If it is just one lesion, what is your
follow-up policy?’
Dermatologist ‘Well then it is one follow-up visit, ehm
mostly after like 8 weeks, to evaluate the
treatment effect. And after that they don’t
need to come back. If patients have like
really chronic multiple AKs, then they
come back few times a year, sometimes
once per 6 months, but we mostly try
once a year’. (Dermatologist interview 14)
‘My colleagues have done it [more follow-up then rec-
ommended by the guideline], also to gain more income
with it.’ (Dermatologist interview 9)
Need for improving skin cancer management including
actinic keratosis in primary care
As a result of the high and increasing burden of AK, dermatol-
ogists suggested that GPs need to recognize their role in the
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prevention of skin cancer and that the quality of AK manage-
ment in primary care needs to be improved. According to der-
matologists, this could be achieved by expanding skin cancer
education in general, which also covers the management of
AK. Further mentioned in this respect were the use of biopsies
in cases of diagnostic uncertainty, increasing patient screening
in the form of proactive clinical assessment of cutaneous pho-
todamage, and the use of a cryospray to apply cryotherapy
instead of a cotton-tipped dipstick.
‘Look, I think that those patients with only a few
lesions, that they don’t need to come to us for that. We
are too expensive for that so you need to leave it up to
the GP. But you know, they have a different cryo appa-
ratus with a thing, eh, they actually need to have some-
thing better, that you know what they are doing, eh,
and I would say some better cryo apparatus. I don’t
know what the evidence is of applying nitrogen with a
stick or with a different apparatus, but instinctively I
would say the other is better.’ (Dermatologist
interview 1)
Discussion
This qualitative study confirms the previously found quantita-
tive variation in AK management within and between primary
and secondary care12 and reveals the underlying motives
reported by GPs and dermatologists. In contrast to dermatolo-
gists, GPs reported limitedly conducting proactive clinical
assessment of cutaneous photodamage, mainly due to a per-
ceived lack of value. Cryotherapy was indicated to be the main
and, for some, the only treatment modality among GPs due to
lack of experience with alternatives. In addition, treatment
choices of dermatologists seemed to be more guideline driven;
dermatologists reported taking into account the risk differenti-
ation, patient preferences and other patient factors. Follow-up
care seemed to vary largely among both GPs and dermatolo-
gists and was reported to be mainly patient driven. Particularly
in secondary care, patient preferences were reported to result
in more extensive follow-up schedules.
GPs reported variations in diagnosing AK and in determin-
ing treatment and follow-up schedules. Whereas some of the
GPs seemed to perform structured and guideline-conforming
AK management, others reported less familiarity with different
aspects of AK care. A commonly reported motive to diverge
from guidelines or refer to secondary care was a lack of
knowledge and experience. For example, the need for a diag-
nostic biopsy was reported as a reason for referral by many
GPs. In addition, many GPs reported using only cryotherapy
(which is generally available in Dutch primary care practices)
due to a lack of experience with other treatment modalities.
This is consistent with the findings of a previous quantitative
study on AK management, showing that GPs use limited treat-
ment modalities.12
The perceived lack of knowledge and experience of AK
among GPs is probably related to limited education on skin
cancer management in GP training and may lead to a sense of
feeling unqualified to perform skin cancer care.23–25 Investing
in improving GPs’ knowledge of AK may increase GPs’ confi-
dence in performing AK and skin cancer care and subse-
quently lead to more standardized and uniform AK
management in primary care. Additional training and promot-
ing awareness among GPs were previously shown to result in
GPs having a larger role in the treatment of AK and fewer
referrals to secondary care.25–28 In countries with dedicated
and specialized GPs, such as Australia and the U.K., GPs are
more engaged in the management of AK.26–28 Especially with
the challenges regarding ageing populations and rising num-
bers of patients with AK, strengthening primary care physi-
cians’ roles may provide opportunities to relieve the
overburdened secondary care setting.12,25–30
GPs indicated conducting limited clinical assessments of
cutaneous photodamage proactively, which is consistent with
the current primary care guideline on ‘suspicious cutaneous
lesions’, which does not include recommendations concerning
proactive cutaneous photodamage assessments.10 Reported
underlying motives consist mainly of a perceived lack of value
and time, and also of doubt whether this should be a task for
GPs. In contrast, dermatologists reported at least pursuing
proactive photodamage assessment in every patient, as they
believed this is an important aspect of care. Related to this is
the reported difference between GPs and dermatologists in
consistently conducting FBSEs, which has also been found in a
previous quantitative study.24
In the current setting, Dutch GPs primarily respond to the
requests of patients, which are mostly lesion directed and do
not include active overall assessments of photodamage.
Although the risk of skin cancer and the need for treatment
are low for those with solitary AK, both increase with the
extensiveness of AK.2,6,8,10 Evaluating the patient’s skin for
overall photodamage when a patient presents with a single AK
is therefore useful and may help GPs to determine which
patients with AK can be treated in primary care and which
should be referred to secondary care. Stimulating the imple-
mentation of the primary care guideline, in which conducting
an FBSE is recommended,10,31 combined with (continued) AK
and skin cancer education, is therefore advocated to support
GPs’ vital role in this growing population.
Although dermatologists reported striving for guideline-dri-
ven care, patient preferences and other patient-related factors
often seem to influence treatment choices. A recent study
showed significant variation between patients regarding their
preferred treatment for AK, and it was therefore advocated
that patient preferences should be taken into account to
increase treatment compliance.32 With patient-centred care
becoming increasingly important in modern medicine, inte-
grating patient preferences becomes more important as
well.32–35 To facilitate dermatologists in managing patient
preferences, a shared decision-making tool may be integrated
within the AK guidelines.36–38 Our study also indicated that
patient preferences may often lead to extensive follow-up regi-
mens among dermatologists; however, the AK guideline for
© 2019 The Authors. British Journal of Dermatology
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secondary care advises to restrict follow-up only to high-risk
patients.1 As providing (extensive) follow-up care to patients
with AK can be considered low-value care, efforts to reduce
patients’ need for follow-up care may be useful, for example
by providing personalized patient information or changes in
framing the information given by physicians.39,40
The strength of this study is that it provides an in-depth
understanding of healthcare providers’ management of AK.
Although previous quantitative research signalled specific AK
practices in primary and secondary care, this qualitative study
helps to reveal the underlying motives. Moreover, by inter-
viewing both GPs and dermatologists, collating information
of primary and secondary care provides a comprehensive
overview of current opinions and views concerning AK care.
Patient preferences were found to be important in physi-
cians’ motives to perform AK care. However, we did not
include patients in our study as patients’ perceived needs
and preferences according to the physicians determine their
practices.
A limitation to be considered in interpreting our findings is
that the interviews were conducted immediately prior to the
issuing of the primary care guideline. Although it is expected
to have influenced GPs’ behaviour to some extent, implemen-
tation of changes in practice can in fact take many years.41–43
Guidelines are often not applied uniformly in practice, and
the development of a guideline alone does not necessarily lead
to a change in clinical practice.42,43 For example, if the value
of AK management is considered to be low, GPs may not be
inclined to follow guideline recommendations in practice. For
the implementation of a guideline to be successful, multi-
faceted and barrier-driven interventions are often needed (i.e.
interventions that are based on a prior barrier analysis among
the stakeholders), adapted to the preferences of the stakehold-
ers.19,20 Finally, although this study is set within the context
of the Dutch healthcare system, we believe our findings are
also valuable to other countries dealing with similar AK issues,
particularly those with comparable GP gatekeeper systems.
In conclusion, this qualitative study provides insight into the
underlying motives of the current AK management of GPs and
dermatologists. Adequate implementation of the primary care
guideline combined with (continuing) AK education for GPs is
needed to address the commonly reported barriers of lack of
value, experience and knowledge. For efficient use of care
among dermatologists, shared decision-making tools along
with adequate (framing of) patient information may be useful.
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